Molecular studies on the role of IL4 & IL13 in fibrosis
IL4 作用的分子研究
基本信息
- 批准号:7208962
- 负责人:
- 金额:$ 32.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-04-15 至 2009-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAutoantibodiesBinding SitesChloramphenicol Acetyl Transferase GeneCollagenCollagen GeneCutaneousDNA BindingDataData ReportingDevelopmentDisruptionDominant-Negative MutationExhibitsExonsFBN1FibroblastsFibrosisGene ExpressionGenesGenetic TranscriptionGoalsHumanHyperplasiaIL4 geneImmunotherapyIn VitroInterleukin-13Interleukin-4JUN geneKineticsKnowledgeLaboratoriesLeadLungMAP Kinase GeneMAPK14 geneMediatingMolecularMusMutatePathway interactionsPatientsPharmaceutical PreparationsPhysiologicalPulmonary EmphysemaRoleSclerodermaSclerosisSerumSignal PathwaySkinSyndromeT-LymphocyteTimeTranscriptional ActivationTransgenic MiceUp-Regulationbaseconceptcytokinefusion genegene interactionin vivopromoterresearch studytranscription factor
项目摘要
DESCRIPTION (provided by applicant): The thrust of our application is based on two groups of findings. Our previous data demonstrate a role for profibrogenic cytokines in the occurrence of skin fibrosis in TSK mice that develop a scleroderma-like syndrome. TSK mice do not develop skin sclerosis following disruption of IL-4, IL-4R gene, or TGF-gene. The lack of a compensatory effect on collagen synthesis by TGF gein mice with a disrupted IL-4R gene suggests that IL-4 may influence the expression of TGF gene in fibroblasts. Additionally, reported data demonstrate that levels of profibrogenic cytokines are elevated in the serum of human scleroderma patients. Little is known of the molecular mechanisms by which IL-4 and IL-13 up-regulate collagen expression. Specifically, the signaling pathways that lead to over-synthesis of collagen and formation of fibrosis as well as the molecular basis of the epistatic interaction between IL-4 and TGF-genes are not known. The overall goal of this application is to address these questions. The specific aims are as follow:
1. To characterize the role of IL-4 and IL-13 in STAT-6-dependent pathways leading to up-regulation of collagen expression in normal and TSK fibroblasts. This wilt be studied by investigating STAT-6 activation, promoter activity, collagen transcription, and collagen synthesis in fibroblasts stimulated with IL-4 and IL-13.
2. To delineate the molecular mechanisms of the IL-4 and TGF-gene interaction that regulate the expression of collagen genes. This will be studied using a set of deletion constructs containing the TGF-gene promoter followed by the CAT gene; the effects of IL-4 and IL-13 on promoter activity will be assessed. We will also study the DNA binding of STAT-6 to the TGF-gene promoter. AP-1, SP-1, NF-1, GATA3, and c-Maf transcription factors will also be examined since the DNA binding sites for these transcription factors have been identified.
3. To study the effect of the activation of MAPK modules by IL-4 and IL-13 on the expression of the collagen (I) gene in a human skin fibroblast line. The kinetics of activation of various molecules of ERK, p38, and c- Jun MAPK modules will be examined. The effect of dominant-positive and dominant-negative constructs on collagen gene expression will be studied in the presence or absence of profibrogenic cytokines.
描述(由申请人提供):我们的申请的主旨是基于两组调查结果。我们先前的数据表明促纤维化细胞因子在发生硬皮病样综合征的TSK小鼠皮肤纤维化中的作用。TSK小鼠在IL-4、IL-4 R基因或TGF-基因破坏后不发生皮肤硬化。IL-4受体基因缺失的小鼠TGF基因对胶原合成缺乏代偿作用,提示IL-4可能影响TGF基因在成纤维细胞中的表达。此外,报道的数据表明,促纤维化细胞因子的水平在人硬皮病患者的血清中升高。IL-4和IL-13上调胶原蛋白表达的分子机制知之甚少。具体而言,导致胶原过度合成和纤维化形成的信号传导途径以及IL-4和TGF-基因之间上位相互作用的分子基础尚不清楚。本应用程序的总体目标是解决这些问题。具体目标如下:
1.表征IL-4和IL-13在导致正常和TSK成纤维细胞中胶原表达上调的STAT-6依赖性途径中的作用。这将通过研究IL-4和IL-13刺激的成纤维细胞中STAT-6活化、启动子活性、胶原转录和胶原合成来研究。
2.阐明IL-4和TGF-基因相互作用调节胶原基因表达的分子机制。这将使用一组缺失构建体进行研究,所述缺失构建体含有TGF基因启动子和随后的CAT基因;将评估IL-4和IL-13对启动子活性的影响。我们还将研究STAT-6与TGF-基因启动子的DNA结合。还将检查AP-1、SP-1、NF-1、GATA 3和c-Maf转录因子,因为这些转录因子的DNA结合位点已被鉴定。
3.研究IL-4和IL-13激活MAPK模块对人皮肤成纤维细胞株胶原(I)基因表达的影响。将检查ERK、p38和c-Jun MAPK模块的各种分子的活化动力学。将在存在或不存在促纤维化细胞因子的情况下研究显性阳性和显性阴性构建体对胶原基因表达的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CONSTANTIN A BONA其他文献
CONSTANTIN A BONA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CONSTANTIN A BONA', 18)}}的其他基金
Molecular studies on the role of IL4 & IL13 in fibrosis
IL4 作用的分子研究
- 批准号:
6754187 - 财政年份:2004
- 资助金额:
$ 32.14万 - 项目类别:
Molecular studies on the role of IL4 & IL13 in fibrosis
IL4 作用的分子研究
- 批准号:
6885765 - 财政年份:2004
- 资助金额:
$ 32.14万 - 项目类别:
Molecular studies on the role of IL4 & IL13 in fibrosis
IL4 作用的分子研究
- 批准号:
7039100 - 财政年份:2004
- 资助金额:
$ 32.14万 - 项目类别:
Molecular studies on the role of IL4 & IL13 in fibrosis
IL4 作用的分子研究
- 批准号:
7385945 - 财政年份:2004
- 资助金额:
$ 32.14万 - 项目类别:
Molecular studies on the role of IL-4 & IL-13 in fibrosi
IL-4 作用的分子研究
- 批准号:
6659454 - 财政年份:2003
- 资助金额:
$ 32.14万 - 项目类别:
THE EFFECT OF AGE ON MOLECULAR STRUCTURE AND FUNCTION OF THE ANTIGEN RECEPTOR
年龄对抗原受体分子结构和功能的影响
- 批准号:
6344596 - 财政年份:2000
- 资助金额:
$ 32.14万 - 项目类别:
THE EFFECT OF AGE ON MOLECULAR STRUCTURE AND FUNCTION OF THE ANTIGEN RECEPTOR
年龄对抗原受体分子结构和功能的影响
- 批准号:
6098756 - 财政年份:1999
- 资助金额:
$ 32.14万 - 项目类别:
THE EFFECT OF AGE ON MOLECULAR STRUCTURE AND FUNCTION OF THE ANTIGEN RECEPTOR
年龄对抗原受体分子结构和功能的影响
- 批准号:
6267735 - 财政年份:1998
- 资助金额:
$ 32.14万 - 项目类别:
IMMUNOCHEMICAL AND MOLECULAR STUDIES IN HUMAN SCLERODERMA AND TSK MICE
人类硬皮病和 TSK 小鼠的免疫化学和分子研究
- 批准号:
6099170 - 财政年份:1997
- 资助金额:
$ 32.14万 - 项目类别:
相似海外基金
Defining the cellular origin of pathogenic autoantibodies
定义致病性自身抗体的细胞起源
- 批准号:
EP/Y031091/1 - 财政年份:2024
- 资助金额:
$ 32.14万 - 项目类别:
Fellowship
Do autoantibodies to aberrantly glycosylated MUC1 drive extra-articular rheumatoid arthritis, and can GSK assets prevent driver antigen formation?
针对异常糖基化 MUC1 的自身抗体是否会导致关节外类风湿性关节炎,GSK 资产能否阻止驱动抗原形成?
- 批准号:
MR/Y022947/1 - 财政年份:2024
- 资助金额:
$ 32.14万 - 项目类别:
Research Grant
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 32.14万 - 项目类别:
Operating Grants
Autoantibodies to tumor-derived neoepitopes as biomarkers and immunoPET agents for the early detection of small cell lung cancer
肿瘤衍生新表位的自身抗体作为生物标志物和免疫 PET 试剂用于小细胞肺癌的早期检测
- 批准号:
10715807 - 财政年份:2023
- 资助金额:
$ 32.14万 - 项目类别:
Role of pharmacological activity of autoantibodies in ME/CFS
自身抗体药理活性在 ME/CFS 中的作用
- 批准号:
MR/Y003667/1 - 财政年份:2023
- 资助金额:
$ 32.14万 - 项目类别:
Research Grant
Pathological Mechanisms of Immune-Mediated Cerebellar Ataxia with Associated Sez6L2 Autoantibodies
免疫介导的小脑共济失调与相关 Sez6L2 自身抗体的病理机制
- 批准号:
10740682 - 财政年份:2023
- 资助金额:
$ 32.14万 - 项目类别:
Pathogenesis of idiopathic nephrotic syndrome: defining the role of B cells and autoantibodies reactive to podocyte proteins
特发性肾病综合征的发病机制:定义 B 细胞和足细胞蛋白反应性自身抗体的作用
- 批准号:
487849 - 财政年份:2023
- 资助金额:
$ 32.14万 - 项目类别:
Operating Grants
Depleting autoantibodies for the treatment of autoimmunity
消耗自身抗体来治疗自身免疫
- 批准号:
10481071 - 财政年份:2022
- 资助金额:
$ 32.14万 - 项目类别:
Pathological Mechanisms of Immune-Mediated Cerebellar Ataxia with Associated Sez6L2 Autoantibodies
免疫介导的小脑共济失调与相关 Sez6L2 自身抗体的病理机制
- 批准号:
10526475 - 财政年份:2022
- 资助金额:
$ 32.14万 - 项目类别: